 SAN DIEGO--BUSINESS WIRE--- ITRM ITRM--Shareholder rights law firm Robbins LLP announces that a class action has been filed on behalf of all purchasers of Iterum Therapeutics PLC NASDAQ: ITRM securities between November 30, 2020 and July 23, 2021, for violations of the Securities Exchange Act of 1934. Iterum is a clinic-stage pharmaceutical company that develops anti-infectives for multi-drug resistant pathogens in Ireland and the U.S. If you suffered a loss due to Iterum Therapeutics plc.s misconduct, 